Head-to-head dispatch
Direct Meds vs Tell Her Doc
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A rare compounded desk offering both sublingual drops and injectable on either molecule, at all-inclusive no-membership pricing.
Marked down on: FDA issued directmeds.com, Inc. dba DirectMeds a warning letter in September 2025; the letter is public in FDA's warning-letter database
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Desk Score
Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses.
Marked down on: 'All sales are final' — no refunds once medication has left the pharmacy
Direct Meds takes this head-to-head with the higher Desk Score, 82/100 (B−) against 71/100 (C) for Tell Her Doc. Tell Her Doc still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Direct Meds
82/100
B−
Tell Her Doc
71/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Direct Meds | Tell Her Doc |
|---|---|---|
| Semaglutide | $249/mo sublingual · $297/mo injectable | $269/mo (microdose tier, plus a separate fee, compounded) |
| Tirzepatide | $299/mo sublingual · $399/mo injectable | Not disclosed |
| Coverage | Not publicly listed | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Patients who want a needle-free sublingual option, or the choice between drops and injection, without a membership fee. | Readers who want women-focused compounded semaglutide or tirzepatide in injection, oral or ODT form with a named pharmacy. |
| Desk Score | 82/100B− | 71/100C |
The verdict
Desk pick — Direct MedsDirect Meds takes this head-to-head with the higher Desk Score, 82/100 (B−) against 71/100 (C) for Tell Her Doc. Tell Her Doc still holds its ground where its strengths line up with yours.
Choose Direct Meds if…
Patients who want a needle-free sublingual option, or the choice between drops and injection, without a membership fee.
$249/mo sublingual · $297/mo injectable sema · $299/mo sublingual · $399/mo injectable tirz · Not publicly listed
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Choose Tell Her Doc if…
Readers who want women-focused compounded semaglutide or tirzepatide in injection, oral or ODT form with a named pharmacy.
$269/mo (microdose tier, plus a separate fee, compounded) sema · Not disclosed tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Direct Meds · Tell Her Doc.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Direct Meds vs CoreAge Rx
- Tell Her Doc vs Vaylen
- Direct Meds vs Strut Health
- Tell Her Doc vs Ondra Health
- Direct Meds vs Invigor Medical
- Tell Her Doc vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.